Sterotactic Body Radiation Therapy for Unresectable Liver Metastases from Colorectal Cancer

Official Title

Phase II Trial of Sterotactic Body Radiation Therapy (SBRT) for Unresectable Liver Metastases from Colorectal Carcinoma

Summary:

Annually 10 - 30%  of the 140,000 colorectal cancer patients diagnosed will have liver metastasis. Many of these will be unresectable. Chemotherapy is effective in treating metastatic colorectal cancer, but is unlikely to lead to cure. 

Stereotactic body radiation therapy (SBRT) refers to radiation therapy delivered precisely with a high dose volume conforming closely to the tumour, usually in less than 10 treatment fractions.

Trial Description

See Trial Summary